Integrated BioPharma's total assets for Q2 2025 were $25.66M, a decrease of -1.99% from the previous quarter. INBP total liabilities were $5.93M for the fiscal quarter, a -10.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.